If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?I last covered Atai Life Sciences N.V. (NASDAQ: ATAI ) for Seeking Alpha back in July, giving its stock a Buy rating. A good decision, as it has turned out, given Atai stock now trades at $5.2 perThe group is for b ...